CIP
MEDP icon

Chartwell Investment Partners’s Medpace MEDP Stock Holding History

Chartwell Investment Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-254,116
Closed -$15.2M – 462
2018
Q3 		$15.2M Sell
254,116
-6,107
-2% -$334K 0.45% 60
2018
Q2 		$11.2M Buy
+260,223
New +$10.5M 0.33% 113

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Chartwell Investment Partners's MEDP Position: Q4 2018 in Review

Chartwell Investment Partners sold out of Medpace (MEDP) in Q4 2018, closing a stake of 254,116 shares — an estimated $15.2M sold.

Chartwell Investment Partners first reported a position in MEDP in Q2 2018 and held it in 2 quarters. The position peaked at $15.2M in Q3 2018. 216 funds tracked by Wall St. Rank hold MEDP as of Q4 2018.

  • Chartwell Investment Partners reported no remaining Medpace position as of Q4 2018 after selling out during the quarter.
  • Chartwell Investment Partners sold 254,116 Medpace shares in Q4 2018, an estimated $15.2M.
  • Chartwell Investment Partners first reported a position in Medpace in Q2 2018 and held it in 2 quarters.
  • Chartwell Investment Partners's Medpace position peaked at $15.2M in Q3 2018.
  • 216 funds tracked by Wall St. Rank held Medpace as of Q4 2018.

Based on Chartwell Investment Partners's 13F filing for Q4 2018, filed 1 Feb 2019.